Sfoglia per Autore
Angiogenesis and VEGF expression in preinvasive lesions of the human breast
2004-01-01 Viacava, P; Naccarato, ANTONIO GIUSEPPE; Bocci, Guido; Fanelli, G; Aretini, P; Lonobile, A; Evangelista, Giuseppe; Montruccoli, G; Bevilacqua, Generoso
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents
2005-01-01 Francia, G; Green, Sk; Bocci, Guido; Man, S; Emmenegger, U; Ebos, Jm; Weinerman, A; Shaked, Y; Kerbel, Rs
Fattori che influenzano la risposta ai farmaci
2005-01-01 DEL TACCA, M; Bocci, Guido; Blandizzi, Corrado
Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens
2005-01-01 Danesi, Romano; Bocci, Guido; DI PAOLO, Antonello
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells
2005-01-01 Bocci, Guido; Fioravanti, Anna; Orlandi, Paola; Bernardini, Nunzia; Collecchi, P; DEL TACCA, M; Danesi, Romano
Cytotoxic drugs
2005-01-01 Danesi, Romano; Bocci, Guido; DI PAOLO, Antonello; DEL TACCA, M.
Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose
2005-01-01 Shaked, Y; Bocci, Guido; Munoz, R; Man, S; Ebos, Jml; Hicklin, Dj; Bertolini, F; D'Amato, R; Kerbel, Rs
Idarubicin and idarubicinol effects on breast cancer multicellular spheroids
2005-01-01 Orlandi, P; Barbara, C; Bocci, Guido; Fioravanti, A; DI PAOLO, Antonello; DEL TACCA, M; Danesi, Romano
Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling
2005-01-01 DI PAOLO, Antonello; Danesi, Romano; Ciofi, L; Vannozzi, F; Bocci, Guido; Lastella, M; Amatori, F; Martelloni, Bm; Ibrahim, T; Amadori, D; Falcone, Alfredo; DEL TACCA, M.
Farmacocinetica
2005-01-01 DEL TACCA, M; Danesi, Romano; DI PAOLO, Antonello; Bocci, Guido
5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice
2005-01-01 Innocenti, F; Danesi, Romano; Bocci, Guido; Natale, Gianfranco; DEL TACCA, M.
Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
2005-01-01 Bocci, Guido; Tuccori, M; Emmenegger, U; Liguori, V; Falcone, Alfredo; Kerbel, Rs; DEL TACCA, M.
Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients
2006-01-01 DI PAOLO, Antonello; Bocci, Guido; Danesi, Romano; DEL TACCA, M.
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
2006-01-01 Allegrini, G; DI PAOLO, Antonello; Cerri, E; Cupini, S; Amatori, F; Masi, G; Danesi, Romano; Marcucci, L; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo
Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination
2006-01-01 Fontana, A.; Bocci, Guido; Galli, L.; Fontana, E.; Antonuzzo, A.; Galli, C.; Loupakis, F.; Allegrini, G.; DI MARSICO, R.; Landi, L.; LO DICO, M.; Mazzoni, E.; Safina, V.; Barletta, M.; Andreuccetti, M.; Barsanti, G.; Fioravanti, A.; Orlandi, P.; DEL TACCA, M.; Falcone, Alfredo
Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical and pharmacodynamic evaluation
2006-01-01 Loupakis, F.; Bocci, Guido; Allegrini, G.; Cerri, E.; Barletta, M. T.; Masi, G.; Fioravanti, A.; Orlandi, P.; DEL TACCA, M.; Falcone, Alfredo
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients
2006-01-01 DI PAOLO, Antonello; M., Lencioni; F., Amatori; S., DI DONATO; F., Federici; Bocci, Guido; Falcone, Alfredo; S., Ricci; M., DEL TACCA; Danesi, Romano
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
2006-01-01 Barbara, C; Orlandi, P; Bocci, Guido; Fioravanti, A; DI PAOLO, Antonello; Natale, Gianfranco; DEL TACCA, M; Danesi, Romano
Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination
2006-01-01 A., Fontana; Bocci, Guido; E., Fontana; C., Galli; F., Loupakis; L., Landi; M., LO DICO; E., Mazzoni; G., Barsanti; Falcone, Alfredo
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity
2006-01-01 Bocci, Guido; Barbara, C.; Vannozzi, F.; DI PAOLO, Antonello; Melosi, A.; Barsanti, G.; Allegrini, G.; Falcone, Alfredo; Del Tacca, M.; Danesi, Romano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Angiogenesis and VEGF expression in preinvasive lesions of the human breast | 1-gen-2004 | Viacava, P; Naccarato, ANTONIO GIUSEPPE; Bocci, Guido; Fanelli, G; Aretini, P; Lonobile, A; Evangelista, Giuseppe; Montruccoli, G; Bevilacqua, Generoso | |
| Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents | 1-gen-2005 | Francia, G; Green, Sk; Bocci, Guido; Man, S; Emmenegger, U; Ebos, Jm; Weinerman, A; Shaked, Y; Kerbel, Rs | |
| Fattori che influenzano la risposta ai farmaci | 1-gen-2005 | DEL TACCA, M; Bocci, Guido; Blandizzi, Corrado | |
| Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens | 1-gen-2005 | Danesi, Romano; Bocci, Guido; DI PAOLO, Antonello | |
| Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells | 1-gen-2005 | Bocci, Guido; Fioravanti, Anna; Orlandi, Paola; Bernardini, Nunzia; Collecchi, P; DEL TACCA, M; Danesi, Romano | |
| Cytotoxic drugs | 1-gen-2005 | Danesi, Romano; Bocci, Guido; DI PAOLO, Antonello; DEL TACCA, M. | |
| Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose | 1-gen-2005 | Shaked, Y; Bocci, Guido; Munoz, R; Man, S; Ebos, Jml; Hicklin, Dj; Bertolini, F; D'Amato, R; Kerbel, Rs | |
| Idarubicin and idarubicinol effects on breast cancer multicellular spheroids | 1-gen-2005 | Orlandi, P; Barbara, C; Bocci, Guido; Fioravanti, A; DI PAOLO, Antonello; DEL TACCA, M; Danesi, Romano | |
| Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling | 1-gen-2005 | DI PAOLO, Antonello; Danesi, Romano; Ciofi, L; Vannozzi, F; Bocci, Guido; Lastella, M; Amatori, F; Martelloni, Bm; Ibrahim, T; Amadori, D; Falcone, Alfredo; DEL TACCA, M. | |
| Farmacocinetica | 1-gen-2005 | DEL TACCA, M; Danesi, Romano; DI PAOLO, Antonello; Bocci, Guido | |
| 5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice | 1-gen-2005 | Innocenti, F; Danesi, Romano; Bocci, Guido; Natale, Gianfranco; DEL TACCA, M. | |
| Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation | 1-gen-2005 | Bocci, Guido; Tuccori, M; Emmenegger, U; Liguori, V; Falcone, Alfredo; Kerbel, Rs; DEL TACCA, M. | |
| Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients | 1-gen-2006 | DI PAOLO, Antonello; Bocci, Guido; Danesi, Romano; DEL TACCA, M. | |
| Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation | 1-gen-2006 | Allegrini, G; DI PAOLO, Antonello; Cerri, E; Cupini, S; Amatori, F; Masi, G; Danesi, Romano; Marcucci, L; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo | |
| Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination | 1-gen-2006 | Fontana, A.; Bocci, Guido; Galli, L.; Fontana, E.; Antonuzzo, A.; Galli, C.; Loupakis, F.; Allegrini, G.; DI MARSICO, R.; Landi, L.; LO DICO, M.; Mazzoni, E.; Safina, V.; Barletta, M.; Andreuccetti, M.; Barsanti, G.; Fioravanti, A.; Orlandi, P.; DEL TACCA, M.; Falcone, Alfredo | |
| Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical and pharmacodynamic evaluation | 1-gen-2006 | Loupakis, F.; Bocci, Guido; Allegrini, G.; Cerri, E.; Barletta, M. T.; Masi, G.; Fioravanti, A.; Orlandi, P.; DEL TACCA, M.; Falcone, Alfredo | |
| 5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients | 1-gen-2006 | DI PAOLO, Antonello; M., Lencioni; F., Amatori; S., DI DONATO; F., Federici; Bocci, Guido; Falcone, Alfredo; S., Ricci; M., DEL TACCA; Danesi, Romano | |
| In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma | 1-gen-2006 | Barbara, C; Orlandi, P; Bocci, Guido; Fioravanti, A; DI PAOLO, Antonello; Natale, Gianfranco; DEL TACCA, M; Danesi, Romano | |
| Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination | 1-gen-2006 | A., Fontana; Bocci, Guido; E., Fontana; C., Galli; F., Loupakis; L., Landi; M., LO DICO; E., Mazzoni; G., Barsanti; Falcone, Alfredo | |
| A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity | 1-gen-2006 | Bocci, Guido; Barbara, C.; Vannozzi, F.; DI PAOLO, Antonello; Melosi, A.; Barsanti, G.; Allegrini, G.; Falcone, Alfredo; Del Tacca, M.; Danesi, Romano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile